| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
Apuli Maricel serves as a Chief Accounting Officer at BBIO. Across recent SEC filings that breaks down to 0 buys and 7 sells. Those positions are worth an estimated $9.8M at current prices.
Historically, Apuli Maricel's trades have earned a below-average insider score of 19/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -77.8%.
The biggest single holding is BBIO (~$9.8M) as Chief Accounting Officer. The recent filings there lean toward selling, a net 10,536 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 2,000 | $80.06 | $160,120.00 | -1.5% | - | - | |
| Apr 30, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 2,000 | $71.58 | $143,160.00 | -1.5% | - | - | |
| Feb 26, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 2,000 | $66.00 | $132,000.00 | -1.6% | - | - | |
| Feb 17, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 510 | $74.31 | $37,898.10 | -0.4% | - | - | |
| Dec 8, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 2,000 | $74.26 | $148,520.00 | -1.5% | -11.6% | - | |
| Aug 7, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 1,000 | $45.44 | $45,440.00 | -0.7% | +36.4% | - | |
| May 2, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Accounting Officer | Sell | 1,026 | $38.51 | $39,509.11 | -0.7% | +22.6% | +77.8% |